SPDR® S&P Biotech ETF (XBI)

117.59
Delayed Data
As of Oct 23
 +0.55 / +0.47%
Today’s Change
62.94
Today|||52-Week Range
122.82
+23.64%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Moderna Expects COVID-19 Vaccine Data in November: ETFs to Gain
Oct 22 / Zacks.com - Paid Partner Content
Trump vs. Biden: ETF Strategies for the Election Outcome
Oct 15 / Zacks.com - Paid Partner Content
Trump vs. Biden: ETF Strategies for the Election Outcome
Oct 19 / Zacks.com - Paid Partner Content
Biotech ETFs to Shine on Coronavirus Antibodies Progress
Oct 12 / Zacks.com - Paid Partner Content
Weekly ETF Roundup: Broad U.S. Equity Tops, Biotech Flops
Oct 19 / Zacks.com - Paid Partner Content
 

Performance

1 month+7.74% 3 years+11.79%
3 months+2.37% 5 years+12.56%
1 year+46.26% Since inception+14.61%
Data through 10/24/2020

Quote Details

Previous close$117.04
Open day’s range116.15 – 117.79
Net asset value (NAV)117.50 (10/23/2020)
Daily volume2,831,687
Average volume (3 months)5,082,151
Data as of 4:37pm ET, 10/23/2020

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+12.56%+10.93%
Expense Gross exp ratio0.35%1.22%
Risk 5 year sharpe ratio0.510.59
Net assets$5.2B$3.5B
Average market cap$3.2B$40.5B
Average P/E--29.8
Dividend / Share--0.27%

Competitors

IHI iShares U.S. Medical Devices ETF
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IMMU Immunomedics Inc1.87%
SRNE Sorrento Therapeutics Inc1.64%
BPMC Blueprint Medicines Corp1.30%
EXAS Exact Sciences Corp1.24%
NVTA Invitae Corp1.24%
SGEN Seagen Inc1.21%
ARWR Arrowhead Pharmaceuticals Inc1.20%
MRTX Mirati Therapeutics Inc1.17%
XLRN Acceleron Pharma Inc1.16%
OPK OPKO Health Inc1.15%